Susan Richman

Topoisomerase-1 (Topo1) as a predictive and prognostic factor in colorectal cancer chemotherapy

Susan Richman, L. C. Thompson, Phil Quirke, 2009 .

Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning

Jens Rittscher, Clare Verrill, Susan Richman, 2019, bioRxiv.

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification

Susan Richman, Mark Lawler, Tim Maughan, 2017, Nature Communications.

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

Susan Richman, Phil Quirke, Gary Middleton, 2013, The Lancet. Oncology.